Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-12-01
著者
-
TAKEUCHI Tsutomu
Division of Particle and Astrophysical Sciences, Nagoya University
-
Kameda Hideto
Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Japa
-
Kameda Hideto
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Takeuchi Tsutomu
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
SUZUKI KATSUYA
Division of Marine Environment and Resources, Graduate School of Fisheries Sciences, Hokkaido Univer
-
SEKIGUCHI Naoya
Division of Rheumatology, Department of Internal Medicine, Saitama Medical Center
-
AMANO Koichi
Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
-
Amano Koichi
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Amano Koichi
Division Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Kameda Hideto
Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Faculty Of Medicine
-
NAGASAWA Hayato
Division of Rheumatology/Clinical Immunology, Department of Internal Medicine, Saitama Medical Cente
-
TAKEI Hirofumi
Division of Rheumatology/Clinical Immunology, Department of Internal Medicine, Saitama Medical Cente
-
NISHI Eiko
Division of Rheumatology/Clinical Immunology, Department of Internal Medicine, Saitama Medical Cente
-
OGAWA Hiroe
Division of Rheumatology/Clinical Immunology, Department of Internal Medicine, Saitama Medical Cente
-
Kameda Hideto
Division Of Rheumatology Saitama Medical Center Saitama Medical School
-
Nishi Eiko
Division Of Rheumatology/clinical Immunology Department Of Internal Medicine Saitama Medical Center
-
Ogawa Hiroe
Division Of Rheumatology/clinical Immunology Department Of Internal Medicine Saitama Medical Center
-
Takei Hirofumi
Division Of Rheumatology/clinical Immunology Department Of Internal Medicine Saitama Medical Center
-
Sekiguchi Naoya
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Amano Kouichi
Division Of Rheumatology Saitama Medical Center Saitama Medical School
-
Suzuki Katsuya
Division Of Rheumatology/clinical Immunology Department Of Internal Medicine Saitama Medical Center
-
Nagaoka Shouhei
Department Of Rheumatology Yokohama Minami Kyosai Hospital
-
Kameda Hideto
Department Of Rheumatology/clinical Immunology Saitama Medical Center
-
Amano Koichi
Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Saitama Medical Cen
-
Takeuchi Tsutomu
Division Of Particle And Astrophysical Sciences School Of Science Nagoya University
-
Nagasawa Hayato
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Nagasawa Hayato
Division Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
関連論文
- Exploring Galaxy Evolution from Infrared Number Counts and Cosmic Infrared Background
- Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of Pneumocystis Pneumonia in Japan Revealed by a Multicenter Study
- Validity and visualization of a numerical model used to determine dynamic configurations of fishing nets
- Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion
- Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis : results from the RISING study
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy
- T-cell receptor ζmRNA with an alternatively spliced 3' untranslated region is generated predominantly in the peripheral blood T cells of systemic lupus erythematosus patients
- Molecular mechanism of the decreased expression of TCRζ in systemic lupus erythematosus patients
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J)